[1] |
Strashilov S, Yordanov A. Aetiology and pathogenesis of cutaneous melanoma: current concepts and advances [J]. Int J Mol Sci, 2021,22(12):6395. doi: 10.3390/ijms22126395.
|
[2] |
Michielin O, van Akkooi ACJ, Ascierto PA, et al. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow⁃up[J]. Ann Oncol, 2019,30(12):1884⁃1901. doi: 10.1093/annonc/mdz411.
|
[3] |
Gorlov IP, Conway K, Edmiston SN, et al. Methylation of nonessential genes in cutaneous melanoma ⁃ Rule Out hypothesis [J]. Melanoma Res, 2023,33(3):163⁃172. doi: 10.1097/CMR. 0000000000000881.
|
[4] |
Yang S, Wei J, Cui YH, et al. m(6)A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti⁃PD⁃1 blockade[J]. Nat Commun, 2019,10(1):2782. doi: 10.1038/s41467⁃019⁃10669⁃0.
|
[5] |
Zhang X, Yu K, Ma L, et al. Endogenous glutamate determines ferroptosis sensitivity via ADCY10⁃dependent YAP suppression in lung adenocarcinoma[J]. Theranostics, 2021,11(12):5650⁃5674. doi: 10.7150/thno.55482.
|
[6] |
Chen SL, Hu F, Wang DW, et al. Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia[J]. Aging (Albany NY), 2020,12(12):11864⁃11877. doi: 10.18632/aging. 103357.
|
[7] |
Zhang Y, Qiu Z, Wei L, et al. Integrated analysis of mutation data from various sources identifies key genes and signaling pathways in hepatocellular carcinoma[J]. PLoS One, 2014,9(7):e100854. doi: 10.1371/journal.pone.0100854.
|
[8] |
Chao X, Miao F, Feng X, et al. ADCY2 rs10059539 C>T polymorphism confers a decreased risk of hepatocellular carcinoma in Chinese Han women[J]. Eur J Cancer Prev, 2021,30(5):351⁃356. doi: 10.1097/CEJ.0000000000000638.
|
[9] |
Fan Y, Mu J, Huang M, et al. Epigenetic identification of ADCY4 as a biomarker for breast cancer: an integrated analysis of adenylate cyclases[J]. Epigenomics, 2019,11(14):1561⁃1579. doi: 10.2217/epi⁃2019⁃0207.
|
[10] |
Zhou R, Wen Z, Liao Y, et al. Evaluation of stromal cell infiltration in the tumor microenvironment enable prediction of treatment sensitivity and prognosis in colon cancer[J]. Comput Struct Biotechnol J, 2022,20:2153⁃2168. doi: 10.1016/j.csbj. 2022.04.037.
|
[11] |
Wei J, Wu Y, Zhang X, et al. Type 2 diabetes is more closely associated with risk of colorectal cancer based on elevated DNA methylation levels of ADCY5[J]. Oncol Lett, 2022,24(1):206. doi: 10.3892/ol.2022.13327.
|
[12] |
Deris Zayeri Z, Parsi A, Shahrabi S, et al. Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic and prognostic biomarkers in colorectal cancer[J]. Cancer Cell Int, 2023,23(1):264. doi: 10.1186/s12935⁃023⁃03117⁃z.
|
[13] |
Shen⁃Gunther J, Xia Q, Stacey W, et al. Molecular pap smear: validation of HPV genotype and host methylation profiles of ADCY8, CDH8, and ZNF582 as a predictor of cervical cytopathology[J]. Front Microbiol, 2020,11:595902. doi: 10. 3389/fmicb.2020.595902.
|
[14] |
Guo R, Liu T, Shasaltaneh MD, et al. Targeting adenylate cyclase family: new concept of targeted cancer therapy[J]. Front Oncol, 2022,12:829212. doi: 10.3389/fonc.2022.829212.
|
[15] |
Jung J, Bollag WB. Phenformin: AMP(K)ed for potential repurposing[J]. J Invest Dermatol, 2021,141(1):11⁃14. doi: 10.1016/j.jid.2020.06.008.
|
[16] |
Penugurti V, Mishra YG, Manavathi B. AMPK: an odyssey of a metabolic regulator, a tumor suppressor, and now a contextual oncogene[J]. Biochim Biophys Acta Rev Cancer, 2022,1877(5):188785. doi: 10.1016/j.bbcan.2022.188785.
|
[17] |
Chen MH, Malbon CC. G⁃protein⁃coupled receptor⁃associated A⁃kinase anchoring proteins AKAP5 and AKAP12: differential trafficking and distribution[J]. Cell Signal, 2009,21(1):136⁃142. doi: 10.1016/j.cellsig.2008.09.019.
|
[18] |
Shirafuji T, Shimazaki H, Miyagi T, et al. Spinocerebellar ataxia type 14 caused by a nonsense mutation in the PRKCG gene[J]. Mol Cell Neurosci, 2019,98:46⁃53. doi: 10.1016/j.mcn.2019. 05.005.
|